Introduction: Enoxaparin is a complex and biologically derived low-molecular-weight Heparin which... more Introduction: Enoxaparin is a complex and biologically derived low-molecular-weight Heparin which is approved for a variety of clinical indications associated with thromboembolic events such as Deep Vein Thrombosis and Venous Thromboembolism. During COVID-19 it was frequently used as prophylaxis in the treatment of thromboembolic events. Nowadays, many brands have come up in the market for the same. Objective: In Tricolour Hospital located in Vadodara, Gujarat, the ongoing brand of Enoxaparin 0.6 i.e., Clexane (Sanofi) falls short as well as in the pharmaceutical market. Hence, the management decided to procure another brand of Enoxaparin until Clexane is available to the vendors. Therefore, the present study was planned to study efficacy of two brands of Enoxaparin –one is Coguparine, (Venus Pharmaceuticals) and another LMWX- (Abbott) in COVID-19 patients in an isolation ward of hospital. The aim of present study was to compare the efficacy of two brands of Enoxaparin (Coguparine v...
COVID-19 Drug Development - Recent Advances, New Perspectives, and Applications [Working Title]
COVID 19 is widely regarded as one of the worst pandemics of the twenty-first century. The World ... more COVID 19 is widely regarded as one of the worst pandemics of the twenty-first century. The World Health Organization (WHO) named the viral infection caused by the new coronavirus (COVID-19), which was first reported in December 2019, as severe acute respiratory syndrome-Coronavirus-2 (SARS-CoV2), and it became a cause of death for many all over the world. As a result, a unique inquiry and clinical trial to find a solution for this catastrophic pandemic disease is under way. To manage and eradicate the disease, effective vaccinations and antiviral therapies are urgently needed. There were no treatments or vaccines available for this fatal virus at first, but several medications that are used to treat other diseases are now being used to treat Covid19. Remdesivir has been licenced for therapy since it has shown to shorten hospital stays. Corticosteroids reduced mortality in patients requiring oxygen supplementation or mechanical ventilation. The purpose of this review is to make reade...
Introduction: Enoxaparin is a complex and biologically derived low-molecular-weight Heparin which... more Introduction: Enoxaparin is a complex and biologically derived low-molecular-weight Heparin which is approved for a variety of clinical indications associated with thromboembolic events such as Deep Vein Thrombosis and Venous Thromboembolism. During COVID-19 it was frequently used as prophylaxis in the treatment of thromboembolic events. Nowadays, many brands have come up in the market for the same. Objective: In Tricolour Hospital located in Vadodara, Gujarat, the ongoing brand of Enoxaparin 0.6 i.e., Clexane (Sanofi) falls short as well as in the pharmaceutical market. Hence, the management decided to procure another brand of Enoxaparin until Clexane is available to the vendors. Therefore, the present study was planned to study efficacy of two brands of Enoxaparin –one is Coguparine, (Venus Pharmaceuticals) and another LMWX- (Abbott) in COVID-19 patients in an isolation ward of hospital. The aim of present study was to compare the efficacy of two brands of Enoxaparin (Coguparine v...
COVID-19 Drug Development - Recent Advances, New Perspectives, and Applications [Working Title]
COVID 19 is widely regarded as one of the worst pandemics of the twenty-first century. The World ... more COVID 19 is widely regarded as one of the worst pandemics of the twenty-first century. The World Health Organization (WHO) named the viral infection caused by the new coronavirus (COVID-19), which was first reported in December 2019, as severe acute respiratory syndrome-Coronavirus-2 (SARS-CoV2), and it became a cause of death for many all over the world. As a result, a unique inquiry and clinical trial to find a solution for this catastrophic pandemic disease is under way. To manage and eradicate the disease, effective vaccinations and antiviral therapies are urgently needed. There were no treatments or vaccines available for this fatal virus at first, but several medications that are used to treat other diseases are now being used to treat Covid19. Remdesivir has been licenced for therapy since it has shown to shorten hospital stays. Corticosteroids reduced mortality in patients requiring oxygen supplementation or mechanical ventilation. The purpose of this review is to make reade...
Uploads
Papers by Jhanvi Patel